Kim De Veirman

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (38)

Anke Maes

Vrije Universiteit Brussel

BELGIUM

View details

Niels Vandewalle

Vrije Universiteit Brussel

BELGIUM

View details

Emma M. Kerr

UNITED KINGDOM

View details

Ken Maes

Scientist genetic profiling of cancer

BELGIUM

View details

Wout De Mey

Vrije Universiteit Brussel

BELGIUM

View details

Cleo Goyvaerts

Vrije Universiteit Brussel

BELGIUM

View details

Yannick De Vlaeminck

Vrije Universiteit Brussel

BELGIUM

View details

Ann Massie

Vrije Universiteit Brussel

BELGIUM

View details

Karine Breckpot

Professor

Vrije Universiteit Brussel

BELGIUM

View details

Catharina Muylaert

Vrije Universiteit Brussel

BELGIUM

View details

Hannelore Ceuppens

Vrije Universiteit Brussel

BELGIUM

View details

Yanmeng Wang

Vrije Universiteit Brussel

BELGIUM

View details

Philip Dunne

Reader in Molecular Pathology and Early Detection

UNITED KINGDOM

View details

Robin Maximilian Awad

Vrije Universiteit Brussel

BELGIUM

View details

Ann De Becker

Vrije Universiteit Brussel

BELGIUM

View details

Oliver Treacy

Lecturer Above the Bar

Ollscoil na Gaillimhe – University of Galway

IRELAND

View details

Ahmet Krasniqi

Vrije Universiteit Brussel

BELGIUM

View details

Inge Oudaert

Vrije Universiteit Brussel

BELGIUM

View details

Rong Fan

Vrije Universiteit Brussel

BELGIUM

View details

Marcus Rohnke

GERMANY

View details

Matthias D'Huyvetter

Vrije Universiteit Brussel

BELGIUM

View details

Eline Menu

BELGIUM

View details

Janik Puttemans

Vrije Universiteit Brussel

BELGIUM

View details

Emile Joseph Clappaert

Vrije Universiteit Brussel

BELGIUM

View details

Quentin Lecocq

Vrije Universiteit Brussel

BELGIUM

View details

Gamze Ates

Vrije Universiteit Brussel

BELGIUM

View details

Arne Wyns

Vrije Universiteit Brussel

BELGIUM

View details

Philip Vlummens

Vrije Universiteit Brussel

BELGIUM

View details

Lien Ann Van Hemelrijck

Vrije Universiteit Brussel

BELGIUM

View details

Jerome Moreaux

Professor

University of Montpellier

FRANCE

View details

Michael Gelinsky

GERMANY

View details

Thomas Ritter

University of Galway

IRELAND

View details

Fien Meeus

Vrije Universiteit Brussel

BELGIUM

View details

Thomas Ertveldt

Vrije Universiteit Brussel

BELGIUM

View details

Francis Impens

Associate Professor

Ghent University

BELGIUM

View details

Emma Verheye

Vrije Universiteit Brussel

BELGIUM

View details

Elke De Bruyne

Vrije Universiteit Brussel

BELGIUM

View details

Nick Devoogdt

Vrije Universiteit Brussel

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kim De Veirman

Research Interests

Explore related searches

Contact this professor

Articles (20)

Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages

AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

Fueling CARs

Targeting mTOR signaling pathways in multiple myeloma

S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma

Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment

Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

Radiotheranostic Agents in Hematological Malignancies

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers

Metabolic cross-talk within the bone marrow milieu

Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma

Aberrant DNA methylation in multiple myeloma

Collaborators (38)

Anke Maes

Niels Vandewalle

Emma M. Kerr

Ken Maes

Wout De Mey

Cleo Goyvaerts

Yannick De Vlaeminck

Ann Massie

Karine Breckpot

Catharina Muylaert

Hannelore Ceuppens

Yanmeng Wang

Philip Dunne

Robin Maximilian Awad

Ann De Becker

Oliver Treacy

Ahmet Krasniqi

Inge Oudaert

Rong Fan

Marcus Rohnke

Matthias D'Huyvetter

Eline Menu

Janik Puttemans

Emile Joseph Clappaert

Quentin Lecocq

Gamze Ates

Arne Wyns

Philip Vlummens

Lien Ann Van Hemelrijck

Jerome Moreaux

Michael Gelinsky

Thomas Ritter

Fien Meeus

Thomas Ertveldt

Francis Impens

Emma Verheye

Elke De Bruyne

Nick Devoogdt

Make your next move.